Taking into account the recent acquisition of Nevro, the net sales for the fiscal year 2025 are projected to be between $2.80 billion and $2.90 billion, with net EPS estimated to be in the range of $3 ...

Taking into account the recent acquisition of Nevro, the net sales for the fiscal year 2025 are projected to be between $2.80 billion and $2.90 billion, with net EPS estimated to be in the range ...

On December 1, 2024, Nevro Corp. became aware of a security incident on its network. Upon detection, Nevro launched an investigation with the assistance of third-party cyber security experts to ...

On December 1, 2024, Nevro Corp. became aware of a security incident on its network. Upon detection, Nevro launched an investigation with the assistance of third-party cyber security experts to ...

StockNews.com started coverage on shares of Nevro (NYSE:NVRO – Free Report) in a report released on Monday morning. The brokerage issued a hold rating on the medical equipment provider’s stock.

Globus Medical, Inc. GMED recently completed its previously disclosed acquisition of Nevro Corp., a global medical device company that delivers comprehensive, life-changing solutions for the ...

Globus Medical, Inc. GMED recently completed its previously disclosed acquisition of Nevro Corp., a global medical device company that delivers comprehensive, life-changing solutions for the treatment ...

The increasing global incidence of chronic diseases—such as arthritis, epilepsy, Parkinson’s disease, depression, and cardiovascular disorders—has accelerated the demand for alternative treatment ...

Credit: T Schneider / Shutterstock. Globus Medical has completed its acquisition of the US-based medical device company Nevro, broadening its market presence in musculoskeletal solutions. The deal, ...